Symptom contributors to quality of life in schizophrenia: Exploratory factor and network analyses
Samuel M. Murphy, Ana T. Flores, Jessica A. Wojtalik, Matcheri S. Keshavan, and Shaun M. Eack
While many evidence-based practices (EBPs) devote significant effort to reducing positive symptomatology for those experiencing schizophrenia and associated disorders, emerging research argues that other symptoms, (such as cognitive deficits, negative symptoms, and affective symptoms), are more likely to impact quality of life (QoL) Findings suggest that strongest indicators of QoL are negative and affective symptoms rather than the commonly treated positive symptoms. Providers and researchers should prioritize the development and implementation of interventions that address the entire spectrum of schizophrenia symptoms to effectively promote the highest possible QoL for those experiencing schizophrenia.
Key Insights:
· Treatment modalities that target negative, affective, and other symptom areas could augment the effectiveness of more commonly used EBPs.
· Greater access to community mental health programs, including service coordination and supported employment, could also be helpful in improving environmental QoL for those experiencing schizophrenia.